ELI Lilly is spending another US$3 billion to build out its US manufacturing footprint as it ramps up production of its ...
Prescription fills for weight loss drugs more than doubled in 2024 despite limited insurance coverage and high costs, ...
Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs.
DealBook Summit, Lilly CEO David Ricks said GLP-1 drugs have the potential to treat more than obesity — including heart disease and substance use disorders.
(Reuters) - Eli Lilly said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant ...
Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.
FILE PHOTO: U.S. Food and Drug Administration (FDA) Commissioner Robert Califf testifies before a Senate Health, Education, ...
I mean, look at me, I’m a bombshell.” Weight loss drugs like Ozempic have made headlines in recent years with celebrities like Sharon Osbourne trying it.
Mounjaro has been reserved for those with a body mass index above 35, as well as with an obesity-related illness. Sky's ...
Ozempic and similar drugs have been linked to possibly helping diseases beyond diabetes and obesity. Are they miracle drugs?
The UK’s advertising watchdog has told ITV News it will tackle “illegal, unacceptable and unfair” adverts for weight-loss injection. | ITV National News ...